Leukocyte profiles differ between type 1 and type 2 diabetes and are associated with metabolic phenotypes: Results from the German Diabetes Study (GDS)

Diabetes Care

Volumn 37, Issue 8, 2014, Pages 2326-2333

  Menart Houtermans, Barbara ^a,b   Rütter, Ruth ^a,b   Nowotny, Bettina ^a   Rosenbauer, Joachim ^a,b   Koliaki, Chrysi ^a,b   Kahl, Sabine ^a,b   Simon, Marie Christine ^a,b   Szendroedi, Julia ^a,b,c   Schloot, Nanette C ^a   Roden, Michael ^a,b,c  

^a HEINRICH HEINE UNIVERSITY   (Germany)

^b LEIBNIZ CENTER FOR DIABETES RESEARCH AT HEINRICH HEINE UNIVERSITY DÜSSELDORF   (Germany)

^c UNIVERSITY HOSPITAL DÜSSELDORF   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

LIPID; GLUCOSE BLOOD LEVEL;

ADULT; AGE; AGED; ARTICLE; BLOOD SAMPLING; BODY MASS; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; DISEASE DURATION; ENDOCRINE PANCREAS FUNCTION TEST; FEMALE; FLOW CYTOMETRY; GENDER; GLYCEMIC CONTROL; HELPER CELL; HUMAN; HYPERINSULINEMIC EUGLYCEMIC CLAMP TEST; IMMUNE STATUS; IMMUNOREGULATION; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN SENSITIVITY; LEUKOCYTE COUNT; LIPID BLOOD LEVEL; LYMPHOCYTE ACTIVATION; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; METABOLISM; MONOCYTE; NATURAL KILLER CELL; NON INSULIN DEPENDENT DIABETES MELLITUS; PHENOTYPE; REGULATORY T LYMPHOCYTE; T LYMPHOCYTE; T LYMPHOCYTE SUBPOPULATION; ADOLESCENT; BLOOD; GERMANY; GLUCOSE BLOOD LEVEL; GLUCOSE CLAMP TECHNIQUE; IMMUNOLOGY; IMMUNOPHENOTYPING; INSULIN RESISTANCE; MIDDLE AGED; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; BLOOD GLUCOSE; BODY MASS INDEX; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; FEMALE; FLOW CYTOMETRY; GERMANY; GLUCOSE CLAMP TECHNIQUE; HUMANS; IMMUNOPHENOTYPING; INSULIN RESISTANCE; LEUKOCYTE COUNT; MALE; MIDDLE AGED; PHENOTYPE; YOUNG ADULT;

EID: 84905040916     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc14-0316     Document Type: Article

References (40)

1. Bluestone JA, Herold K, Eisenbarth G. Genetics, pathogenesis and clinical interventions in type 1 diabetes. Nature 2010; 464: 1293-1300
2. Pham MN, Hawa MI, Pfleger C, et al; Action LADA Study Group. Pro- and anti-inflammatory cytokines in latent autoimmune diabetes in adults, type 1 and type 2 diabetes patients: Action LADA 4. Diabetologia 2011; 54: 1630-1638
3. Pfleger C, Meierhoff G, Kolb H., Schloot NC; p520/521 Study Group. Association of T cell reactivity with beta cell function in recent onset type 1 diabetes patients. J Autoimmun 2010; 34: 127-135
4. Herder C, Baumert J, Thorand B., et al. Chemokines as risk factors for type 2 diabetes: results from the MONICA/KORA Augsburg study, 1984-2002. Diabetologia 2006; 49: 921-929
5. Donath MY, Shoelson SE Type 2 diabetes as an inflammatory disease. Nat Rev Immunol 2011; 11: 98-107
6. Gkrania-Klotsas E., Ye Z, Cooper A.J., et al. Differential white blood cell count and type 2 diabetes: systematic review and meta-analysis of cross-sectional and prospective studies. PLoS ONE 2010; 5: e13405
7. Libby P, Ridker PM, Maseri A. Inflammation and atherosclerosis. Circulation 2002; 105: 1135-1143
8. Long SA, Buckner JH CD4+FOXP3+ T regulatory cells in human autoimmunity: more than a numbers game. J Immunol 2011; 187: 2061-2066
9. Kukreja A, Cost G, Marker J., et al. Multiple immuno-regulatory defects in type-1 diabetes. J Clin Invest 2002; 109: 131-140
10. Honkanen J, Nieminen JK, Gao R, et al IL-17 immunity in human type 1 diabetes. J Immunol 2010; 185: 1959-1967
11. Lindley S, Dayan CM, Bishop A, Roep B.O., Peakman M., Tree TIM. Defective suppressor function in CD4(+)CD25(+) T cells from patients with type 1 diabetes. Diabetes 2005; 54: 92-99
12. Liu W, Putnam AL, Xu-Yu Z, et al. CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ T reg cells. J Exp Med 2006; 203: 1701-1711
13. McClymont SA, Putnam AL, Lee M.R., et al. Plasticity of human regulatory T cells in healthy subjects and patients with type 1 diabetes. J Immunol 2011; 186: 3918-3926
14. Seddiki N, Santner-Nanan B, Martinson J., et al. Expression of interleukin (IL)-2 and IL-7 receptors discriminates between human regulatory and activated T cells. J Exp Med 2006; 203: 1693-1700
15. Jagannathan-Bogdan M., McDonnell ME, Shin H, et al Elevated proinflammatory cytokine production by a skewed T cell compartment requires monocytes and promotes inflammation in type 2 diabetes. J Immunol 2011; 186: 1162-1172
16. Zeng C, Shi X, Zhang B, et al. The imbalance of Th17/Th1/Tregs in patients with type 2 diabetes: relationship with metabolic factors and complications. J Mol Med (Berl) 2012; 90: 175-186
17. Szendroedi J, Schmid AI, Chmelik M, et al Insulin-stimulated mitochondrial ATP synthesis occurs independently of intramyocellular lipid accumulation in well-controlled type 2 diabetic humans. PLoS Med 2007; 4: e154
18. Tripathy D, Wessman Y, Gullström M, Tuomi T., Groop L. Importance of obtaining independent measures of insulin secretion and insulin sensitivity during the same test: results with the Botnia clamp. Diabetes Care 2003; 26: 1395-1401
19. MacIver NJ, Michalek RD, Rathmell JC Metabolic regulation of T lymphocytes. Annu Rev Immunol 2013; 31: 259-283
20. Duncan BB, Schmidt MI, Pankow J.S., et al; Atherosclerosis Risk in Communities Study. Low-grade systemic inflammation and the development of type 2 diabetes: the atherosclerosis risk in communities study. Diabetes 2003; 52: 1799-1805
21. Dandona P, Aljada A, Bandyopadhyay A. Inflammation: the link between insulin resistance, obesity and diabetes. Trends Immunol 2004; 25: 4-7
22. van der Windt GJW, Pearce EL. Metabolic switching and fuel choice during T cell differentiation and memory development. Immunol Rev 2012; 249: 27-42
23. Hanefeld M, Schaper F, Koehler C., et al. Effect of acarbose on postmeal mononuclear blood cell response in patients with early type 2 diabetes: the AI(I)DA study. Horm Metab Res 2009; 41: 132-136
24. Samaras K, Viardot A, Botelho N.K., Jenkins A., Lord RV. Immune cell-mediated inflammation and the early improvements in glucose metabolism after gastric banding surgery. Diabetologia 2013; 56: 2564-2572
25. Del Prato S., Nosadini R, Tiengo A., et al. Insulin-mediated glucose disposal in type I diabetes: evidence for insulin resistance. J Clin Endocrinol Metab 1983; 57: 904-910
26. Kacerovsky M, Brehm A, Chmelik M., et al. Impaired insulin stimulation of muscular ATP production in patients with type 1 diabetes. J Intern Med 2011; 269: 189-199
27. Yki-Järvinen H. Glucose toxicity. Endocr Rev 1992; 13: 415-431
28. Szendroedi J, Roden M. Ectopic lipids and organ function. Curr Opin Lipidol 2009; 20: 50-56
29. Kolb H, Mandrup-Poulsen T. An immune origin of type 2 diabetes? Diabetologia 2005; 48: 1038-1050
30. DeFronzo RA, Simonson D, Ferrannini E. Hepatic and peripheral insulin resistance: a common feature of type 2 (non-insulin-dependent) and type 1 (insulin-dependent) diabetes mellitus. Diabetologia 1982; 23: 313-319
31. Hotamisligil GS. Inflammation and metabolic disorders. Nature 2006; 444: 860-867
32. Nokoff NJ, Rewers M, Cree Green M. The interplay of autoimmunity and insulin resistance in type 1 diabetes. Discov Med 2012; 13: 115-122
33. Daniele G, Guardado Mendoza R, Winnier D, et al The inflammatory status score including IL-6, TNF-α, osteopontin, fractalkine, MCP-1 and adiponectin underlies whole-body insulin resistance and hyperglycemia in type 2 diabetes mellitus. Acta Diabetol 2014; 51: 123-131
34. Federici M, Hribal ML, Menghini R, et al Timp3 deficiency in insulin receptor-haploinsufficient mice promotes diabetes and vascular inflammation via increased TNF-α. J Clin Invest 2005; 115: 3494-3505
35. Perseghin G, Lattuada G, Danna M., et al. Insulin resistance, intramyocellular lipid content, and plasma adiponectin in patients with type 1 diabetes. Am J Physiol Endocrinol Metab 2003; 285: E1174-E1181
36. Szendroedi J, Phielix E, Roden M. The role of mitochondria in insulin resistance and type 2 diabetes mellitus. Nat Rev Endocrinol 2012; 8: 92-103
37. Atkinson MA. The pathogenesis and natural history of type 1 diabetes. Cold Spring Harb Perspect Med 2012; 2: a007641
38. Bulum T, Kolaric B, Duvnial L. Decreased serum monocytes and elevated neutrophils as additional markers of insulin resistance in type 1 diabetes. Int J Diabetes Dev Ctries 2013
39. Willcox A, Richardson SJ, Bone A.J., Foulis AK, Morgan NG. Analysis of islet inflammation in human type 1 diabetes. Clin Exp Immunol 2009; 155: 173-181
40. Bradshaw EM, Raddassi K, Elyaman W., et al. Monocytes from patients with type 1 diabetes spontaneously secrete proinflammatory cytokines inducing Th17 cells. J Immunol 2009; 183: 4432-4439